Stoke Therapeutics (STOK) Treasury Shares (2023 - 2025)
Stoke Therapeutics (STOK) posted quarterly Treasury Shares of $61000.0 for Q4 2025, down 95.01% year-over-year from $1.2 million in Q4 2024, and down 95.01% quarter-over-quarter from $1.2 million in Q4 2024.
Stoke Therapeutics (STOK) Treasury Shares (2023 - 2025) Analysis & Trends
Stoke Therapeutics' Treasury Shares history runs 3 years deep, the most recent figure standing at $61000.0 for Q4 2025.
- In Q4 2025, Treasury Shares fell 95.01% year-over-year to $61000.0; the TTM figure through Dec 2025 stood at $61000.0 (down 95.01% YoY), while the FY2025 annual figure was $61000.0, down 95.01% from the prior year.
- Treasury Shares for Q4 2025 stood at $61000.0, down from $1.2 million in the prior quarter.
- The five-year high for Treasury Shares was $1.5 million in Q4 2023, with the low at $61000.0 in Q4 2025.
- The 3-year median for Treasury Shares is $1.2 million (2024), against an average of $932347.0.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares fell 19.18% in 2024, then slumped 95.01% in 2025.
- Stoke Therapeutics' Treasury Shares stood at $1.5 million in 2023, then slipped by 19.18% to $1.2 million in 2024, then plunged by 95.01% to $61000.0 in 2025.
- Business Quant data shows STOK's Treasury Shares at $61000.0 in Q4 2025, $1.2 million in Q4 2024, and $1.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Stoke Therapeutics | 1.95 Bn | 1.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 1.22 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Dec 31, 2023 | 1.51 Mn |